MedTech & Digital Health

Federal funding for medical devices, diagnostics platforms, and digital health innovation.

We help medtech and digital-health teams pursue ARPA-H, NIH, and BARDA pathways with clinical credibility, regulatory awareness, and compliant submissions.

Who this is for

Medical device, diagnostics, digital therapeutics, and health-AI companies pursuing ARPA-H, NIH, and BARDA funding.

What we do

  • ARPA-H / NIH / BARDA pathway selection
  • Clinical and technical narrative development for federal reviewers
  • Proposal QA, teaming, and post-award planning

Focus areas

  • ARPA-H transformative health: High-risk health moonshots across diagnostics, devices, and care delivery innovation.
  • NIH institute pathways: NCI, NHLBI, and related institutes for device-adjacent and translational research.
  • BARDA health security devices: Diagnostics and platform technologies with medical countermeasure relevance.

Programs

  • ARPA-H Funding: Pursue ARPA-H Innovative Solutions Openings with high-risk health moonshot positioning and compliant packaging.
  • NIH NCI Funding: Pursue National Cancer Institute opportunities with institute-fit strategy, compliant proposal support, and execution planning.
  • NIH NHLBI Funding: Align cardiovascular, pulmonary, and blood-focused innovations to NHLBI pathways with proposal and execution support.
  • BARDA Funding: Develop BARDA-aligned strategies and submissions for health security programs requiring technical, regulatory, and execution discipline.
  • BARDA EZ-BAA Support: Pursue BARDA EZ-BAA opportunities with topic-fit strategy, compliant technical packages, and transition-aware execution planning.

Agencies

ARPA-H, NIH, BARDA, FDA-adjacent programs